Trials / Completed
CompletedNCT03613467
Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC Patients
Vedio-assisted Thoracoscopic Lobectomy vs Open Lobectomy for Patients With Surgically Resectable Pathologic N2 NSCLC
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,145 (actual)
- Sponsor
- Tang-Du Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study was designed to compare the safety and effectiveness of vedio-assisted thoracoscopic lobectomy with open lobectomy for patients with surgically resectable pathologic N2 non-small cell lung cancer
Detailed description
The is a multi-center retrospective study. Patients with pathologic N2 NSCLC who underwent VATS or open lobectomy between 2014 and 2017 were included into this study. Clinical data on patient demographic, clinical characteristics, treatment and clinical outcomes will be collected to evaluate the safety and effectiveness of video-assisted thoracoscopic lobectomy for pathologic N2 NSCLC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | VATS lobectomy | Patients who received lobectomy by video-assisted thoracoscopic surgery |
| PROCEDURE | Thoracotomy lobectomy | Patients who received lobectomy by thoracotomy |
Timeline
- Start date
- 2018-07-04
- Primary completion
- 2018-07-04
- Completion
- 2018-07-06
- First posted
- 2018-08-03
- Last updated
- 2018-08-09
Locations
10 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03613467. Inclusion in this directory is not an endorsement.